End Taxpayer Funding of Gender Experimentation Act of 2021

Summary

End Taxpayer Funding of Gender Experimentation Act of 2021 This bill modifies provisions relating to federal funding for, and health insurance coverage of, gender reassignment medical interventions, which include surgical remedies and hormone therapy arising from a conflict between an individual's gender identity and the sex the individual has or was identified as having at birth. Specifically, the bill prohibits the use of federal funds for gender reassignment medical interventions or for health coverage that includes such interventions. Additionally, such interventions may not be provided in a federal health care facility or by a federal employee. Under current law, coverage of these interventions through Medicare and Medicaid is generally determined at the state level. The bill's restrictions regarding the use of federal funds do not apply to treatment of individuals with medically verifiable disorders of sex development, such as individuals born with atypical development of chromosomal, gonadal, or anatomical sex. The bill also prohibits qualified health plans from including coverage for gender reassignment medical interventions. Further, plans that include coverage for such interventions are not eligible for federal subsidies.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 16 March 2021

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

2. 16 March 2021

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 16 March 2021

   Introduced

   Introduced in House

   Source: IntroReferral

4. 16 March 2021

   Introduced

   Introduced in House

   Source: IntroReferral

5. 17 March 2021

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

6. 18 May 2021

   Referred

   Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 16 March 2021 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 16 March 2021

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 16 March 2021

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 16 March 2021

  Open at official source

Sponsors

• Doug LaMalfa · R · Sponsor
• Rep. Norman, Ralph [R-SC-5] · R · Sponsor
• Rep. Allen, Rick W. [R-GA-12] · R · Sponsor
• Rep. Grothman, Glenn [R-WI-6] · R · Sponsor
• Jeff Duncan · R · Sponsor
• Doug Lamborn · R · Sponsor
• Jody Hice · R · Sponsor
• Rep. Miller, Mary E. [R-IL-15] · R · Sponsor
• W. Steube · R · Sponsor
• Trent Kelly · R · Sponsor
• Jim Jordan · R · Sponsor
• Jim Banks · R · Sponsor
• Rep. Weber, Randy K. Sr. [R-TX-14] · R · Sponsor
• Robert Aderholt · R · Sponsor
• Brian Babin · R · Sponsor
• Bob Good · R · Sponsor
• Lisa McClain · R · Cosponsor
• Rep. Roy, Chip [R-TX-21] · R · Cosponsor
• Rep. Boebert, Lauren [R-CO-4] · R · Cosponsor
• Eric Crawford · R · Cosponsor
• Matthew Rosendale · R · Cosponsor
• Debbie Lesko · R · Cosponsor
• Ken Buck · R · Cosponsor
• Rep. Gosar, Paul A. [R-AZ-9] · R · Cosponsor
• · hsju00 · Standing
• · hsif00 · Standing
• · hswm00 · Standing

Related records

• related to → End Taxpayer Funding of Gender Experimentation Act of 2021
• related to ← Protect Children’s Innocence Act
• related to ← End Taxpayer Funding of Gender Experimentation Act of 2020